Zhejiang Jutai Pharm Company Profile
✉ Email this page to a colleague
What is the competitive landscape for ZHEJIANG JUTAI PHARM
ZHEJIANG JUTAI PHARM has three approved drugs.
Summary for Zhejiang Jutai Pharm
| US Patents: | 0 |
| Tradenames: | 3 |
| Ingredients: | 3 |
| NDAs: | 3 |
Drugs and US Patents for Zhejiang Jutai Pharm
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Zhejiang Jutai Pharm | BUPROPION HYDROCHLORIDE | bupropion hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 211200-001 | Sep 5, 2019 | AB3 | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Zhejiang Jutai Pharm | METOPROLOL SUCCINATE | metoprolol succinate | TABLET, EXTENDED RELEASE;ORAL | 214110-004 | May 15, 2026 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Zhejiang Jutai Pharm | METOPROLOL SUCCINATE | metoprolol succinate | TABLET, EXTENDED RELEASE;ORAL | 214110-002 | Jul 26, 2024 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Zhejiang Jutai Pharm | AMANTADINE HYDROCHLORIDE | amantadine hydrochloride | TABLET;ORAL | 218598-001 | Sep 26, 2024 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
